Editor's note: Seeking Alpha is proud to welcome Jason Najum as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access. Click here to find out more » Fokusiert The Food and Drug Administration (FDA) will soon announce a decision that could have serious repercussions for MindMed investors and the entire psychedelic medicine industry. For decades, an organization ...